157 related articles for article (PubMed ID: 2357770)
1. Evaluation of p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met-ethoxy HCl against transplantable and spontaneous murine neoplasia.
Yagi MJ; Bekesi JG
Cancer Chemother Pharmacol; 1990; 26(3):215-20. PubMed ID: 2357770
[TBL] [Abstract][Full Text] [Related]
2. PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell lines.
Yagi MJ; Chin SE; Scanlon KJ; Holland JF; Bekesi JG
Biochem Pharmacol; 1985 Jul; 34(13):2347-54. PubMed ID: 4040366
[TBL] [Abstract][Full Text] [Related]
3. Differential susceptibility and cytopathic alterations induced by PTT. 119, a new cancericidal compound, p-fluoro-Phe-L-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl.
Yagi MJ; Bekesi JG
Biomed Pharmacother; 1983; 37(7):329-38. PubMed ID: 6667339
[TBL] [Abstract][Full Text] [Related]
4. Increased cancericidal activity of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. I. In vitro cytotoxicity.
Yagi MJ; Bekesi JG; Daniel MD; Holland JF; De Barbieri A
Cancer Chemother Pharmacol; 1984; 12(2):70-6. PubMed ID: 6421500
[TBL] [Abstract][Full Text] [Related]
5. Increased cancericidal activity of PTT.119; a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. II. In vivo bioassay.
Yagi MJ; Zanjani M; Holland JF; Bekesi JG
Cancer Chemother Pharmacol; 1984; 12(2):77-82. PubMed ID: 6697428
[TBL] [Abstract][Full Text] [Related]
6. Interference of mouse mammary tumor virus replication by PTT.119 [p-fluoro-L-phe-m-bis-(2-chloroethyl)amino-L-phe-met ethoxy HCl]--an antitumor agent.
Yagi MJ; Maldarelli F; Chin SE; Holland JF; Bekesi JG
J Natl Cancer Inst; 1986 Mar; 76(3):493-501. PubMed ID: 3005743
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 3-(p-fluorophenyl)-L-alanyl-3-[m-bis-(2-chloroethyl) aminophenyl]-L-alanyl-L-methionine ethyl ester HCl (PTT.119) against xenografts of human rhabdomyosarcoma.
Houghton PJ; Tharp R; Houghton JA; Holland JF; Bekesi JG
Cancer Chemother Pharmacol; 1988; 22(3):201-4. PubMed ID: 3409455
[TBL] [Abstract][Full Text] [Related]
8. Multiple transport pathways for L1210 cells: uptake of PTT.119, a bifunctional alkylator with carrier amino acids.
Yagi MJ; Scanlon KJ; Chin SE; Holland JF; Bekesi JG
Chemotherapy; 1988; 34(3):235-47. PubMed ID: 3416661
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effectiveness of neuraminidase-treated tumor cells as an immunogen in man and experimental animals with leukemia.
Bekesi JG; Roboz JP; Holland JF
Ann N Y Acad Sci; 1976; 277(00):313-31. PubMed ID: 1069551
[TBL] [Abstract][Full Text] [Related]
10. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
[TBL] [Abstract][Full Text] [Related]
11. Effect of a delta 5-homo-aza-steroidal ester in P388 and L1210 murine leukemias.
Catsoulacos P; Camoutsis C; Wampler GL
Oncology; 1982; 39(1):59-60. PubMed ID: 7058047
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of antitumor activity of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-4-iminopyrimidine in murine tumors.
Furusawa S; Mian AM
Cancer Treat Rep; 1987 May; 71(5):441-6. PubMed ID: 3567967
[TBL] [Abstract][Full Text] [Related]
13. Potential antitumor agents: steroidal amidoesters with an alkylating moiety.
Papageorgiou A; Boutis L; Nicolaropoulos S; Catsoulacos P
Oncology; 1987; 44(2):128-32. PubMed ID: 3574853
[TBL] [Abstract][Full Text] [Related]
14. In vivo activity on murine tumors of a novel antitumor compound, N-beta-dimethylaminoethyl 9-carboxy-5-hydroxy-10-methoxybenzo[a]phenazine-6-carboxamide sodium salt (NC-190).
Nakaike S; Yamagishi T; Samata K; Nishida K; Inazuki K; Ichihara T; Migita Y; Otomo S; Aihara H; Tsukagoshi S
Cancer Chemother Pharmacol; 1989; 23(3):135-9. PubMed ID: 2924370
[TBL] [Abstract][Full Text] [Related]
15. Mammary tumor and melanoma cell transport of PTT.119, a bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids.
Yagi MJ; Scanlon KJ; Chin SE; Bekesi JG
Chemotherapy; 1988; 34(1):61-70. PubMed ID: 2832130
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of 9-dimethylaminomethyl-10-hydroxycamptothecin against xenografts derived from adult and childhood solid tumors.
Houghton PJ; Cheshire PJ; Myers L; Stewart CF; Synold TW; Houghton JA
Cancer Chemother Pharmacol; 1992; 31(3):229-39. PubMed ID: 1464161
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of N-(phosphonacetyl)-L-aspartic acid, a transition-state inhibitor of aspartate transcarbamylase.
Johnson RK; Inouye T; Goldin A; Stark GR
Cancer Res; 1976 Aug; 36(8):2720-5. PubMed ID: 1064466
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of tetraacetylglucosamine mustard.
Wampler GL; Nassiri SK; Hsiao YY; Bardos TJ; Regelson W
Cancer Res; 1975 Aug; 35(8):1903-6. PubMed ID: 1149014
[TBL] [Abstract][Full Text] [Related]
19. Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroethyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptide.
Roboz J; Jiang J; Holland JF; Bekesi JG
Cancer Res; 1997 Nov; 57(21):4795-802. PubMed ID: 9354441
[TBL] [Abstract][Full Text] [Related]
20. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon.
Bekesi JG; Roboz JP; Zimmerman E; Holland JF
Cancer Res; 1976 Feb; 36(2 pt 2):631-9. PubMed ID: 1082796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
